Dexcom Stelo vs Abbott Lingo: Best OTC CGM for Wellness in 2026
The Dexcom Stelo and Abbott Lingo are the two leading over-the-counter CGM biosensors available without a prescription. Both target wellness users, prediabetics, and health optimizers rather than diagnosed diabetics. The Stelo uses Dexcom's proven sensor platform and offers a 15-day wear time with a comprehensive app that tracks glucose trends, meal responses, and daily patterns at approximately $99/month. The Lingo uses Abbott's Libre technology, also with a 14-day wear time, and focuses on metabolic coaching with glucose scores and actionable nudges at approximately $49/month. Neither device offers the real-time alerts or insulin pump compatibility found in prescription CGMs.
This head-to-head comparison evaluates 11 specification categories: MARD accuracy, sensor wear time, warmup time, calibration requirements, alert capability, insulin pump compatibility, prescription requirement, insured and uninsured pricing, Medicare coverage, and overall GlucoseIntel rating. Each spec is compared in the table below, with the superior value highlighted. Where the difference is negligible or depends on individual preference, neither value is highlighted.
Dexcom Stelo vs Abbott Lingo: Specification Comparison
| Spec | Dexcom Stelo | Abbott Lingo |
|---|---|---|
| MARD (Accuracy) | 9% | 9% |
| Wear Time | 15 days | 14 days |
| Warmup Time | 30 min | 60 min |
| Calibration Required | No | No |
| Alerts & Alarms | No | No |
| Pump Compatible | No | No |
| Prescription Required | No | No |
| Price (Insured) | N/A — OTC product not covered by insurance | N/A — OTC product not covered by insurance |
| Price (Uninsured) | $49–$99 per month | $49 per month |
| Medicare | No | No |
| Rating | 4.3 | 4.2 |
Feature-by-Feature Analysis
Accuracy (MARD)
Both devices share the same 9% MARD, meaning their accuracy is equivalent in clinical trials. Real-world accuracy may vary slightly based on sensor placement, hydration, and individual physiology.
Wear Time
The Dexcom Stelo lasts 15 days while the Abbott Lingo lasts 14 days. The Dexcom Stelo's longer wear time means fewer sensor changes per year (approximately 25 vs 27), less insertion discomfort, and potentially lower annual costs when fewer sensors are consumed.
Cost
With insurance, the Dexcom Stelo costs N/A — OTC product not covered by insurance per month while the Abbott Lingo costs N/A — OTC product not covered by insurance. Without insurance, the Dexcom Stelo costs $49–$99 per month and the Abbott Lingo costs $49 per month. Neither device is currently Medicare-approved.
Alerts and Alarms
Neither device offers real-time glucose alerts. Both require manual glucose checks by opening the smartphone app. This limits their utility for type 1 diabetes patients or anyone at risk of severe hypoglycemia who needs proactive warnings.
Insulin Pump Compatibility
Neither device is compatible with insulin pump systems. Both are standalone CGMs designed for glucose monitoring only — they cannot drive automated insulin delivery. This is typical for OTC and wellness-focused CGMs that are not designed for insulin-dependent diabetes management.
Who Should Choose Each Device
Choose the Dexcom Stelo if: you prioritize longer wear time, or prefer this product ecosystem.
Choose the Abbott Lingo if: you prioritize this device's specific feature set, or want the most affordable option.
Verdict
Winner: tie
This is a tie because the two products optimize for different priorities. The Dexcom Stelo wins on data depth and app quality — it provides more detailed glucose analytics, better data export options, and a more polished user interface that appeals to data-driven users. The Abbott Lingo wins on price ($49/month vs $99/month) and simplicity — its coaching-focused approach with glucose scores and habit nudges is more approachable for beginners. If budget is the primary concern, the Lingo is the better starting point. If you want the richest glucose data possible, the Stelo delivers more.
Key Takeaways
- Dexcom Stelo and Abbott Lingo serve different segments of the CGM market.
- The winner (tie) offers the better combination of accuracy, features, and value for most users.
- Your individual needs — insurance coverage, pump compatibility, and whether you need alerts — should drive the final decision.
- Both options are viable choices. Read the full reviews linked below for complete specifications and detailed analysis.